bimagrumab tirzepatide New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? | Reviews in Endocrine and Metabolic Disorders A pill could solve the

Arch Neurol 1992;49:1137-41

A large tirzepatide trial pushed average loss even higher, which explains why response differences now matter so much

The increase in risk was small approximately three to four additional cases per 10,000 patients treated with GLP-1s over 18 months, but clinicians and patients should be aware of this potential association. Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety

If plaques improve but flares continue, the immune modulation component may need adjustment

When to Seek Emergency Care Palpitations accompanied by chest pain or pressure Severe shortness of breath Fainting or near-fainting episodes Rapid heartbeat lasting more than a few minutes